One of the principal tools of personalized medicine is the use of companion diagnostics. In this first article in a two-part series on the opportunities and challenges that confront the rise of companion diagnostics, we use case studies to review the different roles that these products and services could play in the continued growth of the pharmaceutical industry. The article can be found here:
SAF to be used in Singapore departing flights from 2026
In this article, Marakon’s Rod Davies shares his thoughts on Singapore’s commitment to mandate the use of Sustainable Aviation Fuel (SAF) for departing...